Regulatory Challenges in Drug Manufacturing

This chapter examines serious cleanliness and compliance issues discovered in a Bloomington drug manufacturing facility recently acquired by Novo. The findings, including the presence of cat hair and other operational problems, raise crucial concerns for several pharmaceutical companies reliant on the plant for drug production and FDA approvals.